Home Site Map Contact Us Trade Online
Company Profile
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Quarterly Results
Financial Ratio
Share Price
MF Holdings
Price Charts
Company News
Cash Flow
Share holding
Deliverable Volume
Historical Volume
Directors Report
Peer Comparison
Board Meetings
Corporate Annoucements
Book Closure
Bonus Issues
AGM
Home Financial Ratio
Financial Ratio
Glaxosmithkline Pharmaceuticals Ltd.
 
BSE Code 500660
ISIN Demat INE159A01016
Book Value 257.25
NSE Code GLAXO
Dividend Yield % 2.15
Market Cap 196608.41
P/E 31.54
EPS(Last 4 Qtrs.) 73.60
Face Value 10  
Particulars Dec 2012Dec 2011Dec 2010Dec 2009Dec 2008
Operational & Financial Ratios          
   Earnings Per Share (Rs)68.15  50.84  68.64  59.61  52.93  
   CEPS(Rs)70.26  53.25  70.72  61.54  54.86  
   DPS(Rs)50.00  45.00  40.00  30.00  40.00  
   Book NAV/Share(Rs)237.30  226.67  227.95  207.68  181.94  
   Tax Rate(%)31.81  28.12  32.96  33.43  34.06  
Margin Ratios          
   Core EBITDA Margin(%)28.18  30.01  30.25  29.47  29.17  
   EBIT Margin(%)30.84  24.26  40.27  39.67  38.85  
   Pre Tax Margin(%)30.83  24.25  40.24  39.65  38.82  
   PAT Margin (%)21.02  17.43  26.98  26.40  25.60  
   Cash Profit Margin (%)21.67  18.26  27.80  27.25  26.53  
Performance Ratios          
   ROA(%)19.39  10.83  12.38  12.07  12.01  
   ROE(%)29.38  22.36  31.51  30.60  30.90  
   ROCE(%)43.00  31.05  46.91  45.83  46.71  
   Asset Turnover(x)0.92  0.62  0.46  0.46  0.47  
   Sales/Fixed Asset(x)10.10  8.37  7.09  6.70  6.38  
   Working Capital/Sales(x)1.55  1.44  1.35  1.35  2.36  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.10  0.12  0.14  0.15  0.16  
   Receivable days13.37  9.78  8.53  10.66  9.97  
   Inventory Days40.69  45.18  45.27  45.93  45.26  
   Payable days46.80  62.05  88.60  85.17  86.64  
Valuation Parameters          
   PER(x)31.78  38.09  34.13  27.01  21.67  
   PCE(x)30.83  36.37  33.13  26.16  20.91  
   Price/Book(x)9.13  8.54  10.28  7.75  6.30  
   Yield(%)2.31  2.32  1.71  1.86  3.49  
   EV/Net Sales(x)6.10  5.97  8.48  6.40  5.31  
   EV/Core EBITDA(x)16.10  15.31  20.21  15.44  12.65  
   EV/EBIT(x)19.26  24.06  20.62  15.77  12.95  
   EV/CE(x)5.43  4.89  3.58  2.73  2.21  
   M Cap / Sales6.86  6.79  9.40  7.29  5.85  
Growth Ratio          
   Net Sales Growth(%)10.71  14.45  12.88  12.67  5.28  
   Core EBITDA Growth(%)7.49  6.42  14.23  11.26  11.74  
   EBIT Growth(%)41.29  -30.94  14.37  11.53  12.03  
   PAT Growth(%)34.06  -25.93  15.15  12.61  13.00  
   EPS Growth(%)34.06  -25.93  15.15  12.61  13.00  
Financial Stability Ratios          
   Total Debt/Equity(x)0.00  0.00  0.00  0.00  0.00  
   Current Ratio(x)3.13  2.99  1.51  1.53  1.30  
   Quick Ratio(x)2.79  2.61  1.42  1.44  1.21  
   Interest Cover(x)2534.09  1830.74  1396.44  2073.36  1294.56  
   Total Debt/Mcap(x)0.00  0.00  0.00  0.00  0.00  
Terms of Use | Disclaimer | Privacy Policy | FeedBack | Open an Account with ZEN | Useful Links | Investor Protection
ZEN SECURITIES LIMITED - SEBI Regn.No.: NSE CM / FAO / CD: INB/F/E230684937 | BSE CM / FAO: INB/F010684935 | MCX-SX CD: INE260684937
MCX SX CM / FAO : INB/F/260684932| NSDL: IN-DP-NSDL-238-2003 | CDSL: IN-DP-CDSL-283-2004 | PMS: INP 936
MUTUAL FUND ARN: 0507 | PFRDA Regn.No.: NPS-POP- 04010 |
ZEN COMTRADE PVT LTD - MCX:12695,FMC No.:MCX/TCM/CORP/0859 | NCDEX:00022,FMC No.:NCDEX/TCM/CORP/0008
© 2006 Zen Securities Ltd. All rights reserved. Designed & Developed Accord Fintech Pvt. Ltd.